Lucy Holt
Overview
Explore the profile of Lucy Holt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kragelund B, Loland C, Montoya G, Hatzakis N, Martinez K, Gajhede M, et al.
Structure
. 2023 Jul;
31(7):747-754.
PMID: 37419096
This meeting report presents the 2022 Annual Meeting of the cluster for Integrative Structural Biology at the University of Copenhagen (ISBUC) and discusses the cluster approach to interdisciplinary research management....
2.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Wu M, Shepherd S, Fendler A, Carr E, Au L, Harvey R, et al.
Cancer Cell
. 2023 Apr;
41(5):821-823.
PMID: 37116490
Wu et al. report that patients with hematologic malignancies have reduced immunity against SARS-CoV-2 Omicron subvariants and Sotrovimab retains neutralizing capacity against all tested Omicron subvariants.
3.
Fendler A, Shepherd S, Au L, Wu M, Harvey R, Wilkinson K, et al.
Cell Rep Med
. 2022 Oct;
3(10):100781.
PMID: 36240755
Patients with blood cancer continue to have a greater risk of inadequate immune responses following three COVID-19 vaccine doses and risk of severe COVID-19 disease. In the context of the...
4.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Schmitt A, et al.
Cancer Cell
. 2022 Apr;
40(4):438.
PMID: 35413273
No abstract available.
5.
Fendler A, Au L, Shepherd S, Byrne F, Cerrone M, Boos L, et al.
Nat Cancer
. 2022 Feb;
2(12):1321-1337.
PMID: 35121900
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study, integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118 were...
6.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F, et al.
Nat Cancer
. 2022 Feb;
2(12):1305-1320.
PMID: 35121899
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring (CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated...
7.
Fendler A, Shepherd S, Au L, Wu M, Harvey R, Schmitt A, et al.
Lancet
. 2022 Jan;
399(10328):905-907.
PMID: 35090602
No abstract available.
8.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Schmitt A, et al.
Cancer Cell
. 2021 Dec;
40(2):114-116.
PMID: 34968417
No abstract available.
9.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F, et al.
Nat Cancer
. 2021 Dec;
2:1321-1337.
PMID: 34950880
CAPTURE (NCT03226886) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated 585 patients following administration of two doses of BNT162b2 or AZD1222 vaccines, administered...
10.
Fendler A, Au L, Shepherd S, Byrne F, Cerrone M, Boos L, et al.
Res Sq
. 2021 Sep;
PMID: 34580668
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study (NCT03226886) integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118...